Nanostructured lipid carriers used for oral delivery of oridonin: An effect of ligand modification on absorption

International Journal of Pharmaceutics

Volumn 479, Issue 2, 2015, Pages 391-398

  Zhou, Xiaotong ^a   Zhang, Xingwang ^a   Ye, Yanghuan ^a   Zhang, Tianpeng ^a   Wang, Huan ^a   Ma, Zhiguo ^a   Wu, Baojian ^a  

^a UNIVERSITY OF JINAN   (China)

Author keywords

Ligand mediated transport; Metabolism; Nanostructured lipid carriers; Oral bioavailability; Oridonin; Permeability

Indexed keywords

BIOTIN; LIGAND; LIPID; NANOCARRIER; NANOSTRUCTURED LIPID CARRIER; ORIDONIN; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; DRUG CARRIER; KAURANE DERIVATIVE; NANOMATERIAL;

ANIMAL EXPERIMENT; ARTICLE; BIOTINYLATION; DISPERSION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG METABOLISM; DRUG PENETRATION; DRUG RELEASE; HYPERBARISM; IN VITRO STUDY; INTESTINE PERFUSION; LIPOLYSIS; MASS SPECTROMETRY; NANOENCAPSULATION; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RAT; ANIMAL; BIOAVAILABILITY; CHEMISTRY; INTESTINE ABSORPTION; ORAL DRUG ADMINISTRATION; PERMEABILITY; SOLUBILITY; SPRAGUE DAWLEY RAT;

ADMINISTRATION, ORAL; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BIOLOGICAL AVAILABILITY; BIOTIN; DITERPENES, KAURANE; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; INTESTINAL ABSORPTION; LIGANDS; LIPIDS; NANOSTRUCTURES; PERMEABILITY; RATS; RATS, SPRAGUE-DAWLEY; SOLUBILITY;

EID: 84921328529     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2014.12.068     Document Type: Article

References (29)

1. C.K. Abrams, M. Hamosh, T.C. Lee, A.F. Ansher, M.J. Collen, J.H. Lewis, S.B. Benjamin, and P. Hamosh Gastric lipase: localization in the human stomach Gastroenterology 95 1988 1460 1464
2. K. Balamurugan, N.D. Vaziri, and H.M. Said Biotin uptake by human proximal tubular epithelial cells: cellular and molecular aspects Am. J. Physiol. Renal 288 2005 F823 831
3. W. Dai, D. Zhang, C. Duan, L. Jia, Y. Wang, F. Feng, and Q. Zhang Preparation and characteristics of oridonin-loaded nanostructured lipid carriers as a controlled-release delivery system J. Microencapsul. 27 2010 234 241
4. A. Di Martino, and V. Sedlarik Amphiphilic chitosan-grafted-functionalized polylactic acid based nanoparticles as a delivery system for doxorubicin and temozolomide co-therapy Int. J. Pharm. 474 2014 134 145
5. B. Gaba, M. Fazil, A. Ali, S. Baboota, J.K. Sahni, and J. Ali Nanostructured lipid (NLCs) carriers as a bioavailability enhancement tool for oral administration Drug Deliv. 2014 10.3109/10717544.2014.898110
6. W. Liu, H. Liu, H. Sun, D. Dong, Z. Ma, Y. Wang, and B. Wu Metabolite elucidation of the Hsp90 inhibitor SNX-2112 using ultraperformance liquid chromatography/quadrupole time-of-flight mass spectrometry (UPLC-QTOF/MS) Xenobiotica 44 2014 455 464
7. M. Muchow, P. Maincent, and R.H. Muller Lipid nanoparticles with a solid matrix (SLN NLC, LDC) for oral drug delivery Drug Dev. Ind. Pharm. 34 2008 1394 1405
8. R.H. Muller, R.D. Petersen, A. Hommoss, and J. Pardeike Nanostructured lipid carriers (NLC) in cosmetic dermal products Adv. Drug Deliv. Rev. 59 2007 522 530
9. T. Nozawa, and T. Imai Prediction of human intestinal absorption of the prodrug temocapril by in situ single-pass perfusion using rat intestine with modified hydrolase activity Drug Metab. Dispos. 39 2011 1263 1269
10. D. Patel, S. Dasgupta, S. Dey, Y.R. Ramani, S. Ray, and B. Mazumder Nanostructured lipid carriers (NLC)-based gel for the topical delivery of aceclofenac preparation, characterization, and in vivo evaluation Sci. Pharm. 80 2012 749 764
11. C.J.H. Porter, N.L. Trevaskis, and W.N. Charman Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs Nat. Rev. Drug Discov. 6 2007 231 248
12. J.P. Qi, Y. Lu, and W. Wu Absorption: disposition and pharmacokinetics of solid lipid nanoparticles Curr. Drug Metab. 13 2012 418 428
13. H.M. Said Cell and molecular aspects of human intestinal biotin absorption J. Nutr. 139 2009 158 162
14. H.M. Said, R. Redha, and W. Nylander A carrier-mediated: Na+ gradient-dependent transport for biotin in human intestinal brush-border membrane vesicles Am. J. Physiol. 253 1987 G631 636
15. H.M. Said, R. Redha, and W. Nylander Biotin transport in the human intestine: site of maximum transport and effect of pH Gastroenterology 95 1988 1312 1317
16. S. Selvamuthukumar, and R. Velmurugan Nanostructured lipid carriers: a potential drug carrier for cancer chemotherapy Lipids Health Dis. 11 2012 159
17. M. Shangguan, Y. Lu, J. Qi, J. Han, Z. Tian, Y. Xie, F. Hu, H. Yuan, and W. Wu Binary lipids-based nanostructured lipid carriers for improved oral bioavailability of silymarin J. Biomater. Appl. 28 2013 887 896
18. J. Shen, D. Zhang, Z. Zhao, L. Jia, D. Zheng, G. Liu, L. Hao, Q. Zhang, X. Tian, C. Li, and H. Guo Synthesis characterization, in vitro and in vivo evaluation of PEGylated oridonin conjugates Int. J. Pharm. 456 2013 80 86
19. H. Sun, H. Wang, H. Liu, X. Zhang, and B. Wu Glucuronidation of capsaicin by liver microsomes and expressed UGT enzymes: reaction kinetics: contribution of individual enzymes and marked species differences Expert Opin. Drug Metab. Toxicol. 10 2014 1325 1336
20. N. Thomas, K. Richter, T.B. Pedersen, R. Holm, A. Mullertz, and T. Rades In vitro lipolysis data does not adequately predict the in vivo performance of lipid-based drug delivery systems containing fenofibrate AAPS J. 16 2014 539 549
21. W. Tian, and S.Y. Chen Recent advances in the molecular basis of anti-neoplastic mechanisms of oridonin Chin. J. Integr. Med. 19 2013 315 320
22. Z. Tian, Y. Yi, H. Yuan, J. Han, X. Zhang, Y. Xie, Y. Lu, J. Qi, and W. Wu Solidification of nanostructured lipid carriers (NLCs) onto pellets by fluid-bed coating preparation, in vitro characterization and bioavailability in dogs Powder Technol. 247 2013 120 127
23. J. Varshosaz, F. Hassanzadeh, H. Sadeghi, and S. Andalib Synthesis of octadecylamine-retinoic acid conjugate for enhanced cytotoxic effects of 5-FU using LDL targeted nanostructured lipid carriers Eur. J. Med. Chem. 54 2012 429 438
24. W. Xu, J. Sun, T.T. Zhang, B. Ma, D.W. Chen, and Z.G. He Determination of equilibrium solubility of oridonin and its apparent oil/water partition coefficient by HPLC J. Shenyang Pharm. Univ. 24 2007 220 222
25. W. Xu, J. Sun, T.T. Zhang, B. Ma, S.M. Cui, D.W. Chen, and Z.G. He Pharmacokinetic behaviors and oral bioavailability of oridonin in rat plasma Acta Pharmacol. Sin. 27 2006 1642 1646
26. X. Zhang, and W. Wu Ligand-mediated active targeting for enhanced oral absorption Drug Discov. Today 19 2014 898 904
27. X. Zhang, J. Qi, Y. Lu, W. He, X. Li, and W. Wu Biotinylated liposomes as potential carriers for the oral delivery of insulin Nanomedicine 10 2014 167 176
28. X.W. Zhang, T.P. Zhang, X.T. Zhou, H.M. Liu, H. Sun, Z.G. Ma, and B.J. Wu Enhancement of oral bioavailability of tripterine through lipid nanospheres: preparation, characterization, and absorption evaluation J. Pharm. Sci.-US 103 2014 1711 1719
29. C.Y. Zhuang, N. Li, M. Wang, X.N. Zhang, W.S. Pan, J.J. Peng, Y.S. Pan, and X. Tang Preparation and characterization of vinpocetine loaded nanostructured lipid carriers (NLC) for improved oral bioavailability Int. J. Pharm. 394 2010 179 185